Roche pushes for corrective statement from Indian Patent Office
This article was originally published in Scrip
Executive Summary
Roche wants the Indian Patent Office to clarify that it has not flouted patent data disclosure norms, with specific reference to the 'working' of its patented products in India as required under Form 27 of the Indian Patent Act.